Orally Administered Phosphatidic Acids and Lysophosphatidic Acids Ameliorate Aspirin-Induced Stomach Mucosal Injury in Mice
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Recent investigations revealed that lysophosphatidic acid (LPA), a phospholipid with a growth factor-like activity, plays an important role in the integrity of the gastrointestinal tract epithelium.
This paper attempts to clarify the effect of orally administered phosphatidic acid (PA) and LPA on aspirin-induced gastric lesions in mice.
Materials and Methods
Phospholipids, a free fatty acid, a diacylglycerol and a triglyceride at 1 mM (5.7 μmol/kg body weight) or 0.1 mM were orally administered to mice 0.5 h before oral administration of aspirin (1.7 mmol/kg). The total length of lesions formed on the stomach wall was measured as a lesion index. Formation of LPA from PA in the mouse stomach was examined by in vitro (in stomach lavage fluid), ex vivo (in an isolated stomach) and in vivo (in the stomach of a living mouse) examinations of phospholipase activity.
Palmitic acid, dioleoyl-glycerol, olive oil and lysophosphatidylcholine did not affect the aspirin-induced lesions. In contrast, phosphatidylcholine (1 mM), LPA (1 mM) and PA (0.1, 1 mM) significantly reduced the lesion index. Evidence for formation of LPA from PA in the stomach by gastric phospholipase A2 was obtained by in vitro, ex vivo and in vivo experiments. An LPA-specific receptor, LPA2, was found to be localized on the gastric surface-lining cells of mice.
Pretreatment with PA-rich diets may prevent nonsteroidal anti-inflammatory drug-induced stomach ulcers.
- Moolenaar WH, van Meeteren LA, Giepmans BNG. The ins and outs of lysophosphatidic acid signaling. BioEssays. 2004;26:870–881. CrossRef
- Tokumura A. Physiological significance of lysophospholipids that act on the lumen side of mammalian lower digestive tracts. J Health Sci. 2011;57:115–128. CrossRef
- Sturm A, Sudermann T, Schulte K-M, Goebell H, Dignass AU. Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterology. 1999;117:368–377. CrossRef
- Deng W, Balazs L, Wang D-A, van Middlesworth L, Tigyi G, Johnson LR. Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis. Gastroenterology. 2002;123:206–216. CrossRef
- Deng W, Shuyu E, Tsukahara R, et al. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology. 2007;132:1834–1851. CrossRef
- Adachi M, Horiuchi G, Ikematsu N, et al. Intragastrically administered lysophosphatidic acid protect against gastric ulcer in rats under water-immersion restraint stress. Dig Dis Sci. 2011;56:2252–2261. CrossRef
- Li C, Dandridge KS, Di A, et al. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med. 2005;202:975–986. CrossRef
- Singla A, Dwivedi A, Saksena S, et al. Mechanisms of lysophosphatidic acid (LPA) mediated stimulation of intestinal apical Cl−/OH− exchange. Am J Physiol Gastrointest Liver Physiol. 2010;298:G182–G189. CrossRef
- Singla A, Kumar A, Priyamvada S, et al. LPA stimulates intestinal DRA gene transcription via LPA2 receptor, PI3 K/AKT, and c-Fos-dependent pathway. Am J Physiol Gastrointest Liver Physiol. 2012;302:G618–G627. CrossRef
- Okudaira S, Yukiura H, Aoki J, et al. Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie. 2010;92:698–706. CrossRef
- Sugiura T, Nakane S, Kishimoto S, Waku K, Yoshioka Y, Tokumura A. Lysophosphatidic acid, a growth factor-like lipid, in the saliva. J Lipid Res. 2002;43:2049–2055. CrossRef
- Tanaka T, Horiuchi G, Matsuoka M, et al. Formation of lysophosphatidic acid, a wound-healing lipid, during digestion of cabbage leaves. Biosci Biotechnol Biochem. 2009;73:1293–1300. CrossRef
- Tanaka T, Kassai A, Ohmoto M, et al. Quantification of phosphatidic acid in foodstuffs using a thin-layer-chromatography-imaging technique. J Agric Food Chem. 2012;60:4156–4161. CrossRef
- Taha AS, McCloskey C, Prasada R, Bezlyak V, et al. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomized, double-blind, placebo-controlled trial. Lancet. 2009;374:119–125. CrossRef
- Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself? Physiol Rev. 2008;88:1547–1565. CrossRef
- Musumba C, Pritchard DM, Pirmohamed M. Cellular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment Pharmacol Ther. 2009;30:517–531. CrossRef
- Lichtenberger LM, Barron M, Marathi U. Association of phosphatidylcholine and NSAIDs as a novel strategy to reduce gastrointestinal toxicity. Drugs Today. 2009;45:877–890.
- Tomisato W, Tanaka K, Katsu T, et al. Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem Biophys Res Commun. 2004;323:1032–1039. CrossRef
- Maity P, Bindu S, Dey S, et al. Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa. J Biol Chem. 2009;284:3058–3068. CrossRef
- Somasundaram S, Rafi S, Hayllar J, et al. Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine. Gut. 1997;41:344–353. CrossRef
- Tomisato W, Tsutsumi S, Hoshino T, et al. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol. 2004;67:575–585. CrossRef
- Tanaka T, Tsutsui H, Hirano K, Koike T, Tokumura A, Satouchi K. Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule. J Lipid Res. 2004;45:2145–2150. CrossRef
- Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917. CrossRef
- Chalvardjian A, Rudnicki E. Determination of lipid phosphorus in the nanomolar range. Anal Biochem. 1970;36:225–230. CrossRef
- Inoue M, Adachi M, Shimizu Y, Tsutsumi T, Tokumura A. Comparison of lysophospholipid levels in rat feces with those in a standard chow. J Agric Food Chem. 2011;59:7062–7067. CrossRef
- Morishige J, Urikura M, Takagi H, et al. A clean-up technology for the simultaneous determination of lysophosphatidic acid and sphingosine-1-phosphate by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a phosphate-capture molecule, Phos-tag. Rapid Commun Mass Spectrom. 2010;24:1075–1084. CrossRef
- Tanaka K, Tomisato W, Hoshino T, et al. Involvement of intracellular Ca2+ levels in nonsteroidal anti-inflammatory drug-induced apoptosis. J Biol Chem. 2005;280:31059–31067. CrossRef
- Dunjic BS, Axelson J, Ar’rajab A, Larsson K, Bengmark S. Gastroprotective capacity of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats. Scand J Gastroenterol. 1993;28:89–94. CrossRef
- Holm BA, Keicher L, Liu M, Sokolowski J, Enhorning G. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol. 1991;71:317–321.
- Lichtenberger LM, Wang Z-M, Romero JJ, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nature Med. 1995;1:154–158. CrossRef
- He D, Natarajan V, Stern R, et al. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E2 release via C/EBP β in human bronchial epithelial cells. Biochem J. 2008;412:153–162. CrossRef
- Murph MM, Liu W, Yu S, et al. Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis. PLoS ONE. 2009;4:e5583. CrossRef
- Tojo H, Ying Z, Okamoto M. Purification and characterization of guinea pig gastric phospholipase A2 of the pancreatic type. Eur J Biochem. 1993;215:81–90. CrossRef
- Uthe JF, Magee WL. Phospholipase A2: action on purified phospholipids as affected by deoxycholate and divalent cations. Can J Biochem. 1971;49:776–784. CrossRef
- Foster DA. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. Biochim Biophys Acta. 2009;1791:949–955. CrossRef
- Cheney G. Rapid healing of peptic ulcers in patients receiving fresh cabbage juice. Calif Med. 1949;70:10–15.
- Orally Administered Phosphatidic Acids and Lysophosphatidic Acids Ameliorate Aspirin-Induced Stomach Mucosal Injury in Mice
Digestive Diseases and Sciences
Volume 58, Issue 4 , pp 950-958
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Lysophosphatidic acid
- Phosphatidic acid
- Non-steroidal anti-inflammatory drug-induced ulcer
- Phospholipase A2
- Dietary lipids
- Industry Sectors
- Author Affiliations
- 1. Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, 770-8505, Japan
- 2. Department of Nutrition and Life Science, Fukuyama University, Fukuyama, 729-0292, Japan